(RS)-citalopram
antidepressant of the selective serotonin reuptake inhibitor (SSRI) class
üksikjuht nähtusest
group of stereoisomers
keemiline struktuur
faili seletus: struktura citalopramu bez wskazanej stereochemii cząsteczki, structure of citalopram with undefined stereochemistry
mass/kaal
324,163792 aatommassiühik[23]
chemical formula
C₂₀H₂₁FN₂O[3]
canonical SMILES
CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F[3]
defined daily dose
active ingredient in
Celexa[25]
World Health Organisation international non-proprietary name
citalopram[26]
medical condition treated
diabetic polyneuropathy[27]
alcohol abuse[27]
neurotic disorder[27]
nicotine dependence[27]
generalized anxiety disorder[28]
significant drug interaction
disopyramide[29]
anagrelide[29]
astemizole[29]
azithromycin[29]
bepridil[29]
chlorpromazine[29]
cisapride[29]
clarithromycin[29]
dofetilide[29]
domperidone[29]
dronedarone[29]
droperidol[29]
erythromycin[29]
flecainide[29]
halofantrine[29]
ibutilide[29]
isocarboxazid[29]
mesoridazine[29]
moxifloxacin[29]
ondansetron[29]
pentamidine[29]
phenelzine[29]
pimozide[29]
probucol[29]
procainamide[29]
procarbazine[29]
quinidine[29]
(±)-deprenyl[29]
sevoflurane[29]
sotalol[29]
sparfloxacin[29]
(RS)-sulpiride[29]
terfenadine[29]
thioridazine[29]
tranylcypromine[29]
physically interacts with
legal status (medicine)
boxed warning[35]
pregnancy category
US pregnancy category C
subjektil on roll
second-generation antidepressive agents[37]
stylized name
Commonsi kategooria
Citalopram
Viited
- ↑ 1,0 1,1 1,2 1,3 1,4 1,5 Global Substance Registration System, 19. november 2016, inglise keel, citalopram, 0DHU5B8D6V
- ↑ CAS Common Chemistry, 8. aprill 2021, WSEQXVZVJXJVFP-UHFFFAOYSA-N, https://commonchemistry.cas.org/detail?cas_rn=59729-33-8
- ↑ 3,0 3,1 3,2 3,3 3,4 PubChem, 19. november 2016, inglise keel, 2771, citalopram
- ↑ 4,0 4,1 4,2 4,3 4,4 4,5 4,6 WSEQXVZVJXJVFP-UHFFFAOYSA-N, InChIKey
- ↑ 5,0 5,1 UniChem
- ↑ 6,0 6,1 ChEBI, 3. oktoober 2016, inglise keel, 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile, 77397
- ↑ DrugBank, inglise keel, 17. november 2015, 00215, Citalopram
- ↑ Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard
- ↑ OpenAlex, 26. jaanuar 2022, https://docs.openalex.org/download-snapshot/snapshot-data-format
- ↑ 10,0 10,1 ChEMBL, 19. november 2016, inglise keel, CITALOPRAM, CHEMBL549
- ↑ KBpedia, 9. juuli 2020
- ↑ ChEBI release 2020-09-01
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 19. november 2016, inglise keel, 7547, citalopram
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 5. veebruar 2021
- ↑ International Chemical Identifier, InChI=1S/C20H21FN2O/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20/h4-9,12H,3,10-11,14H2,1-2H3
- ↑ 16,0 16,1 inferred from InChIKey
- ↑ Freebase Data Dumps, 28. oktoober 2013
- ↑ UMLS 2023, 25. mai 2023, inferred by common MeSH mappings on source and on Wikidata
- ↑ ECHA Substance Infocard database, 27. detsember 2018, 100.056.247, Citalopram, CAS no.: 59729-33-8
- ↑ ChemSpider, 19. november 2016, inglise keel, 2669, Citalopram
- ↑ Medical Subject Headings, 14. märts 2018, D015283
- ↑ Hazardous Substances Data Bank, 10. mai 2021, 28. oktoober 2019, Citalopram, 7042
- ↑ PubChem, 3. oktoober 2016, inglise keel, 2771, citalopram
- ↑ 24,0 24,1 https://www.whocc.no/atc_ddd_index/?code=N06AB04
- ↑ RxNorm, 215928, 14. veebruar 2018
- ↑ ChEMBL, 19. jaanuar 2016, inglise keel, Citalopram, CHEMBL549
- ↑ 27,0 27,1 27,2 27,3 27,4 27,5 N0000148583, 13. detsember 2016, NDF-RT, inglise keel
- ↑ 28,0 28,1 28,2 28,3 28,4 28,5 28,6 28,7 Drug Indications Extracted from FAERS, 2. oktoober 2018
- ↑ 29,00 29,01 29,02 29,03 29,04 29,05 29,06 29,07 29,08 29,09 29,10 29,11 29,12 29,13 29,14 29,15 29,16 29,17 29,18 29,19 29,20 29,21 29,22 29,23 29,24 29,25 29,26 29,27 29,28 29,29 29,30 29,31 29,32 29,33 29,34 29,35 29,36 29,37 29,38 29,39 29,40 29,41 High-priority drug–drug interactions for use in electronic health records
- ↑ 30,00 30,01 30,02 30,03 30,04 30,05 30,06 30,07 30,08 30,09 30,10 30,11 30,12 30,13 30,14 30,15 30,16 30,17 30,18 30,19 30,20 30,21 30,22 30,23 30,24 30,25 30,26 30,27 30,28 30,29 30,30 30,31 30,32 30,33 30,34 30,35 30,36 30,37 30,38 30,39 30,40 30,41 30,42 30,43 30,44 30,45 30,46 30,47 30,48 30,49 30,50 30,51 30,52 30,53 30,54 30,55 30,56 30,57 30,58 30,59 30,60 30,61 30,62 30,63 30,64 30,65 30,66 30,67 30,68 30,69 30,70 30,71 30,72 30,73 30,74 30,75 30,76 30,77 30,78 30,79 30,80 30,81 A reference set of clinically relevant adverse drug-drug interactions, hypothetically
- ↑ 31,00 31,01 31,02 31,03 31,04 31,05 31,06 31,07 31,08 31,09 31,10 31,11 31,12 31,13 A reference set of clinically relevant adverse drug-drug interactions, probably
- ↑ 32,00 32,01 32,02 32,03 32,04 32,05 32,06 32,07 32,08 32,09 32,10 32,11 32,12 32,13 32,14 32,15 32,16 32,17 32,18 32,19 32,20 32,21 32,22 32,23 32,24 32,25 32,26 32,27 32,28 32,29 32,30 32,31 32,32 32,33 32,34 32,35 32,36 32,37 32,38 A reference set of clinically relevant adverse drug-drug interactions, established
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 7547, inglise keel
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 4621, inglise keel
- ↑ FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links., https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802
- ↑ N0000148583, 5. märts 2018, NDF-RT
- ↑ 37,0 37,1 Medical Subject Headings, 15. märts 2018, D015283
- ↑ https://www.ismp.org/recommendations/tall-man-letters-list, 2. september 2022